Skip to main content

Table 1 The analysis of the diversity of rat intestinal microflora (mean ± sem)

From: The influence of the intestinal microflora to the efficacy of Rosuvastatin

 

Antibiotic+Statin

Statin

Water

Robinsoniella

5.41E-01 ± 6.40E-02∆∆∆/***

2.24E-03 ± 1.13E-03n.s.

1.44E-03 ± 4.17E-04

Lactobacillus

8.26E-03 ± 5.96E-03∆∆∆/**

2.20E-01 ± 1.25E-02#

1.45E-01 ± 2.28E-02

Enterococcus

2.40E-01 ± 3.50E-02∆∆∆/***

4.12E-03 ± 2.59E-03n.s.

2.16E-03 ± 7.35E-04

Bacteroides

2.71E-03 ± 2.21E-04∆/*

8.18E-02 ± 2.04E-02n.s.

7.05E-02 ± 1.45E-02

Phascolarctobacterium

1.86E-04 ± 8.38E-05n.s./ n.s.

5.86E-02 ± 2.93E-02n.s.

4.47E-02 ± 6.63E-03

Anaeroplasma

7.97E-02 ± 2.58E-02∆/*

3.92E-05 ± 2.60E-05n.s.

4.91E-05 ± 9.81E-06

Parabacteroides

3.53E-04 ± 4.50E-05∆∆/**

2.54E-02 ± 4.63E-03n.s.

2.93E-02 ± 2.21E-03

Bacillus

3.01E-02 ± 5.06E-03∆∆∆/***

7.36E-04 ± 2.64E-04n.s.

5.50E-04 ± 1.04E-04

Parasutterella

3.93E-05 ± 1.96E-05∆∆∆/**

1.57E-02 ± 1.84E-03n.s.

1.22E-02 ± 1.65E-03

Lachnoclostridium

5.89E-05 ± 4.50E-05n.s./ n.s.

1.69E-02 ± 5.69E-03n.s.

1.00E-02 ± 3.68E-03

Sutterella

1.96E-05 ± 9.81E-06n.s./ n.s.

1.56E-02 ± 8.14E-03n.s.

8.58E-03 ± 7.17E-04

Alistipes

3.34E-04 ± 8.38E-05n.s./ n.s.

1.26E-02 ± 9.48E-03n.s.

9.21E-03 ± 3.73E-03

Blautia

9.81E-06 ± 9.81E-06n.s./ n.s.

4.36E-03 ± 2.55E-03n.s.

3.98E-03 ± 6.99E-04

Peptoclostridium

1.96E-05 ± 1.96E-05∆∆/**

3.96E-03 ± 1.03E-03n.s.

4.19E-03 ± 1.96E-04

Flavonifractor

9.81E-06 ± 9.81E-06∆∆/*

4.17E-03 ± 6.46E-04n.s.

2.81E-03 ± 6.32E-04

Anaerotruncus

7.85E-05 ± 3.54E-05n.s./ n.s.

3.55E-03 ± 3.12E-03n.s.

3.31E-03 ± 8.36E-04

Allobaculum

4.91E-05 ± 2.60E-05n.s./ n.s.

4.29E-03 ± 1.85E-03n.s.

2.57E-03 ± 9.12E-04

Bifidobacterium

0.00E + 00 ± 0.00E + 00∆∆/*

1.28E-04 ± 2.60E-05n.s.

8.83E-05 ± 1.70E-05

  1. ∆ Antibiotic+Statin v.s. Statin
  2. *Antibiotic+Statin v.s. Water
  3. #Statin v.s. Water
  4. *, Δ, # p < 0.05 **, ΔΔ p < 0.01 ***, ΔΔΔ p < 0.001